Tower Cancer Scientific Research

Our Mission and Focus

Inspired by the most promising science, we fund leading researchers, making us a launchpad for additional funding and scientific discoveries here and on the global stage.

Our focus is funding basic scientific research to uncover the mechanisms by which cancer develops and spreads, creating a path to effective treatment and prevention of the disease.

Available Grants

Funding Research for Progress

Our focus is funding basic scientific research to uncover the mechanisms by which cancer develops and spreads, creating a path to effectively treating and preventing the disease.

These grants include: One-Year Career Development Grants Supporting early-career researchers in making significant contributions to the field. Five-Year $500,000 Senior Investigator Grants Enabling established researchers to explore innovative solutions.

Available Grants

2024 Career Development Researchers

Exploring groundbreaking cancer research through our funded researchers and their innovative projects.

Prajish Iyer, PhD

Beckman Research Institute of the City of Hope

$100,000 Tower Career Development Grant

Research Title

John Paul Murad, PhD

University of Southern California - Keck School of Medicine

$100,000 Tower Career Development Grant

Research Title

Anthony Nguyen, MD, PhD

Cedars-Sinai Medical Center

$100,000 Tower Career Development Grant

Research Title

Jinseok Park, PhD

Children's Hospital Los Angeles

$100,000 Tower Career Development Grant

Research Title

See All Funded Researchers

Inspired by the Most Promising Science, We're Creating Outsized Impact

Key Achievements

Career Development Grants awarded by Tower Cancer*

5.1M

Invested in Career Development Grants by Tower Cancer*

62.5M

Additional subsequent funds awarded by others to Tower Cancer grantees for cancer research*

Data reflects contributions from the inception of Tower Cancer's Career Development Grants in 2006 to 2024.

Learn More About Our Impact

Current Research Projects

Stem Cell Reprogramming of Anti-Tumor T Cells

Stem Cell Reprogramming of Anti-Tumor T Cells. Stem Cell Reprogramming of Anti-Tumor T Cells. Stem Cell Reprogramming of Anti-Tumor T Cells.Stem Cell Reprogramming of Anti-Tumor T Cells

View All Funded Research Projects

Scientific Advisory Board

Paul Boutros, PhD, MBA

John Carpten, PhD

Xiaojiang Chen, PhD

Gay M. Crooks, MD

John F. DiPersio, MD, PhD

Mitchell E. Gross, MD, PhD

Steven Jonas, MD, PhD

Michael Karin, PhD

Akil Merchant, MD

Edwin Posadas, MD

Michael F. Press, MD, PhD

Saul Priceman, PhD

Matthew Rettig, MD

Antoni Ribas, MD

Barry Rosenbloom, MD

Fred Rosenfelt, MD

Joshua P. Sasine, MD, PhD

Evanthia Roussos Torres, MD, PhD

Lili Yang, PhD

Impact begins here, and it starts with you.

All of our work is made possible through the support of people like you. Will you join us in the fight for a future free from the burden of cancer?

Donate Now